Fig 2.

Effect of farrerol treatment on APAP-mediated oxidative stress in mice. Mice were administered farrerol (40 mg/kg) i.p. two times. At 1 h after the last dose of farrerol, the mice were administered APAP (400 mg/kg) for 3 h. (A, B) The effects of farrerol on MPO and MDA activities in liver homogenates are shown. (C, D) The effects of farrerol on the SOD and GSH levels are shown. All of the data represent the average from three independent experiments. *p < 0.05 and **p < 0.01 versus the APAP group.